Get our introductory offer at only
*$0.99/month for first 3 months
$29.90/month for the next 9 months
CHINA'S Tasly Pharmaceutical Group is planning to list its biopharma unit in Hong Kong to raise about US$1 billion, in what is likely to be the largest biotech float in the city this year, people with knowledge of the matter said.
The plan comes as Hong Kong Exchanges and...